Eisai, Purdue Pharma declare positive results of SUNRISE 2

Japan |  News | 0 Comment | 17 Oct, 2018

Eisai Co., Ltd. and Purdue Pharma L.P. announced positive topline results from SUNRISE 2, a long-term Phase 3 efficacy and safety evaluation of lemborexant, an investigational agent for sle...Read more

Eisai signs pact with Eurofarma for anti-obesity agent

Japan |  News | 0 Comment | 16 Oct, 2018

Eisai Co., Ltd. has entered into an agreement with Eurofarma Laboratorios, to grant exclusive development and marketing rights for its anti-obesity agent lorcaserin hydrochloride in 17 coun...Read more

Hitachi's heavy ion beam therapy system starts treatment at Osaka

Japan |  News | 0 Comment | 16 Oct, 2018

Hitachi, Ltd. announced that its heavy ion beam therapy system has started treatment at Osaka Heavy Ion Therapy Center as of October 16. This marks the first operation of Hitachi's first he...Read more

Innovus Pharma receives approval from Amazon for expansion in Japan

Japan |  News | 0 Comment | 15 Oct, 2018

Innovus Pharmaceuticals, an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to improve men...Read more

GHIT Fund partners with Ono Pharmaceutical

Japan |  News | 0 Comment | 15 Oct, 2018

The Global Health Innovative Technology (GHIT) Fund has welcomed Ono Pharmaceutical Co., Ltd. (Ono) to join GHIT as a new affiliate partner. Ono, headquartered in Osaka, Japan, is a re...Read more

Scientists develop in vivo skin imaging technology

Japan |  News | 0 Comment | 13 Oct, 2018

A team of scientists from Tohoku University in collaboration with Advantest has developed in vivo skin imaging technology that can simultaneously generate dual-wavelength photoacoustic imag...Read more

GenAhead Bio, ERS Genomics enter into CRISPR/Cas9 license agreement

Japan |  News | 0 Comment | 09 Oct, 2018

GenAhead and ERS Genomics has announced a non-exclusive license agreement to provide GenAhead with access to ERS Genomic’s CRISPR/Cas9 genome editing technology patents. ERS Genomics ...Read more

Novan inks $11M deal with Japanese firm

Japan |  News | 0 Comment | 09 Oct, 2018

US based pharmaceutical company Novan has announced an extended license agreement with Sato Pharmaceutical Co, a Japanese prescription company specializing in dermatology. Novan has scored...Read more

Japan MHLW grants orphan designation to Axicabtagene Ciloleucel

Japan |  News | 0 Comment | 08 Oct, 2018

Daiichi Sankyo Company, Limited has announced that axicabtagene ciloleucel (formerly KTE-C19) has been granted Orphan Drug designation by the Japan Ministry of Health, Labour and Welfare (M...Read more

Orgenesis announces license agreement with HekaBio in Japan

Japan |  News | 0 Comment | 05 Oct, 2018

Orgenesis, a manufacturer, service provider and developer of advanced cell therapies, has announced that it has entered into a License Agreement with HekaBio K.K., pursuant to the Joint Ven...Read more

Researchers develop rapid test for infectious diseases

Japan |  News | 0 Comment | 04 Oct, 2018

Researchers from Eindhoven University of Technology (The Netherlands) and Keio University (Japan) have developed a practicable and reliable way to test for infectious diseases. The test sh...Read more

Tasuku Honjo wins Nobel in medicine

Japan |  News | 0 Comment | 03 Oct, 2018

Japanese scientist Tasuku Honjo has been awarded this year’s Nobel Prize in physiology or medicine, for his discovery of a protein that contributed to the development of an immunother...Read more

Eisai receives FDA approval for antiepileptic drug

Japan |  News | 0 Comment | 01 Oct, 2018

Eisai Co., Ltd. has announced that its U.S. subsidiary Eisai Inc. received approval from the U.S. Food and Drug Administration (FDA) for an indication expansion for Eisai's antiepileptic dr...Read more

GHIT Fund invests in innovative TB diagnostics tools

Japan |  News | 0 Comment | 27 Sep, 2018

The Global Health Innovative Technology (GHIT) Fund, Japan recently announced an investment of approximately 420 million yen ($3.8 million) for a highly sensitive rapid diagnostic kit for t...Read more

PeptiDream announces agreement with Santen Pharmaceutical

Japan |  News | 0 Comment | 26 Sep, 2018

Peptidream Inc., a public Kanagawa-based biopharmaceutical company has announced that it has entered into a broad-based multi-target discovery and development agreement with Osaka-based San...Read more

Anaeropharma Science signs research agreement with Astellas

Japan |  News | 0 Comment | 25 Sep, 2018

Anaeropharma Science Inc. headquartered in Tokyo (hereafter "Anaeropharma") has announced that Anaeropharma and Astellas Pharma Inc. headquartered in Tokyo (hereafter "Astellas") ...Read more

Takeda gets positive CHMP opinion for ALUNBRIG

Japan |  News | 0 Comment | 24 Sep, 2018

Takeda Pharmaceutical Company Limited has announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion, re...Read more

Mylan, Fujifilm receive European marketing authorization for Hulio Biosimilar

Japan |  News | 0 Comment | 24 Sep, 2018

Mylan  and Fujifilm Kyowa Kirin Biologics recently announced that the European Commission (EC) has granted marketing authorization for Hulio (Product Code: FKB327), a biosimilar t...Read more